- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 72.63M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $144.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $189.92M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $131.5M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $13.48M |
| Short Term Investments | Q1 2025 · Mar 31, 2024 | $11.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $847.72M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $825.24M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $413.72M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $332.51M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $535.77M |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $460.55M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $894.7M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $807.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.41B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $1.3B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 72.87M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $37.34M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $15.42M |
| Capex | Q1 2025 · Mar 31, 2024 | $3.98M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$15.71M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.60 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.61 |
| Operating Income | Q1 2025 · Mar 31, 2024 | $56.75M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $224.82M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $327.57M |
| Revenue | Q1 2025 · Mar 31, 2024 | $550.57M |